Podiatrists in Carbondale, IL Accepting Medicare

3 Podiatrists found. Showing 1 - 3

Christopher C Moore, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1235 Cedar Ct, Carbondale, IL 62901 Phone: 618-457-0431    Fax: 618-457-5199

Southern Illinois Foot And Ankle Clinic Ltd Podiatrist Medicare: Medicare Enrolled Practice Location: 1235 Cedar Ct, Carbondale, IL 62901 Phone: 618-457-0431    Fax: 618-457-5199

Basil H Hazimah, DPM Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1235 Cedar Ct, Carbondale, IL 62901 Phone: 618-457-0431    Fax: 618-457-5199

News Archive

Liberal Christians protest Hobby Lobby lawsuit over contraception coverage mandate

A group of liberal Christian activists are protesting Hobby Lobby's decision to sue the Obama administration over its contraception coverage mandate in the health law.

Findings could potentially lead to new drug therapy for Cushing disease

Cushing disease is a life-threatening disorder most commonly triggered by tumors, often benign, in the pituitary glands, resulting in excess production of adrenocorticotrophic hormone.

New bone marrow transplant unit launched in Bangalore, India

A bone marrow transplant can mean the difference between life and death for people with blood cancers and related disorders. But many patients in India can't afford the high treatment costs, and for them a transplant is not an option. This is changing thanks to a newly launched bone marrow transplant unit at M.S. Ramaiah Medical College in Bangalore.

IMUC president to present at Immunotherapeutics Partnering and Deal Making Conference

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that its president and CEO, Manish Singh Ph.D., will be presenting at the Immunotherapeutics Partnering and Deal Making Conference, which will take place in San Diego, California on January 30-31, 2012.

Threshold reports positive results from TH-302 Phase 1/2 clinical trial in pancreatic cancer

Threshold Pharmaceuticals, Inc. today announced updated Phase 1/2 clinical trial results related to the Company's clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the ASCO Gastro Intestinal Cancers Symposium that took place in San Francisco from January 20-22, 2011.

Read more Medical News

› Verified 8 days ago